Document Detail

Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease.
MedLine Citation:
PMID:  20484456     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Consumption of fish and n-3 (omega-3) long-chain polyunsaturated fatty acids (LCPUFAs) has been associated with reduced risk of coronary artery disease (CAD) mortality. OBJECTIVE: The aim was to examine the relation between dietary intake of n-3 LCPUFAs or fish and risk of future coronary events or mortality in patients with well-characterized CAD. DESIGN: This was a substudy of 2412 participants in the Western Norway B Vitamin Intervention Trial with a median follow-up time of 57 mo. Patients aged >18 y diagnosed with CAD (81% men) completed a food-frequency questionnaire at baseline, from which daily intakes of eicosapentaenoic, docosapentaenoic, and docosahexaenoic acids as well as fish were estimated on the basis of diet and intakes of supplements including fish and cod liver oils. The main endpoint was a composite of coronary events, including coronary death, nonfatal acute myocardial infarction, and unstable angina pectoris. RESULTS: The mean (+/-SD) intakes of n-3 LCPUFAs in quartiles 1-4 were 0.58 +/- 0.29, 0.83 +/- 0.30, 1.36 +/- 0.44, and 2.64 +/- 1.18 g/d, respectively. We found no dose-response relation between quartiles of n-3 LCPUFAs (based on intake as percentage of total energy) or fish and coronary events or separate endpoints. A post hoc additive proportional hazards model showed a slightly increased risk of coronary events at an intake of n-3 LCPUFAs < approximately 0.30 g/d. CONCLUSION: Among Norwegian patients with CAD consuming relatively high amounts of n-3 LCPUFAs and fish, there were no significant trends toward a reduced risk of coronary events or mortality with increasing intakes. This trial was registered at as NCT00354081.
Mari S Manger; Elin Strand; Marta Ebbing; Reinhard Seifert; Helga Refsum; Jan E Nordrehaug; Dennis W Nilsen; Christian A Drevon; Grethe S Tell; Oyvind Bleie; Stein E Vollset; Eva R Pedersen; Ottar Nygård
Related Documents :
3296196 - The efficacy of cardiovascular nuclear medicine exercise studies.
16813736 - Rationale for the revascularization arm of the bypass angioplasty revascularization inv...
12108816 - Depression, anxiety, and the cardiovascular system: the cardiologist's perspective.
18773986 - Costs and clinical outcomes in individuals without known coronary artery disease underg...
24665356 - Evening primrose oil ameliorates platelet aggregation and improves cardiac recovery in ...
9487276 - Effect of the novel angiotensin ii type 1 receptor antagonist l-158,809 on acute infarc...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-19
Journal Detail:
Title:  The American journal of clinical nutrition     Volume:  92     ISSN:  1938-3207     ISO Abbreviation:  Am. J. Clin. Nutr.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-21     Completed Date:  2010-07-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376027     Medline TA:  Am J Clin Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  244-51     Citation Subset:  AIM; IM    
Institute of Medicine, University of Bergen, Bergen, Norway.
Data Bank Information
Bank Name/Acc. No.:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cohort Studies
Coronary Disease / epidemiology,  prevention & control*
Fatty Acids / blood
Fatty Acids, Omega-3 / therapeutic use*
Food Habits
Middle Aged
Norway / epidemiology
Phospholipids / blood
Proportional Hazards Models
Randomized Controlled Trials as Topic
Risk Assessment
Reg. No./Substance:
0/Fatty Acids; 0/Fatty Acids, Omega-3; 0/Phospholipids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Do socioeconomic factors shape weight and obesity trajectories over the transition from midlife to o...
Next Document:  The Mineralocorticoid Receptor Is a Constitutive Nuclear Factor in Cardiomyocytes due to Hyperactive...